Skip to content
FP
Company

Updated:

Fusion Pharmaceuticals Inc.

Fusion Pharmaceuticals Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001805890, and its reported...

Overview

Fusion Pharmaceuticals Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001805890, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2024-03-20, it reported annual revenue of USD 2,068,000; net income of USD -94,897,000; total assets of USD 285,836,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Fusion Pharmaceuticals Inc.
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Hamilton, Canada
Incorporated in
Z4
Fiscal year end
December 31
SEC CIK
0001805890

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2023USD$2.1M-$94.9M$285.8M$61.5M-$81.8M
FY2022USD$1.5M-$87.6M$219.1M$43.9M-$73.3M
FY2021USD$1.4M-$81.0M$252.3M$52.9M-$75.7M
FY2020USD—-$78.3M$310.7M$90.5M-$29.8M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
8-K8-K
10-K/A10-K/A
8-K8-K
SC 13D—Form SC 13D
10-K10-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Fusion Pharmaceuticals Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Fusion Pharmaceuticals Inc. | Hamilton Company | Altss